|

IOV-4001 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Iovance Biotherapeutics, Inc.1

Indications

  • Stage III Non-small Cell Lung Cancer1
  • Stage IV Non-small Cell Lung Cancer1
  • Unresectable Melanoma1
  • Metastatic Melanoma1
  • Lung Cancer1

Los Angeles, California1 trial

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

The Angeles Clinic and Research Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.